Cardiac arrest due to left circumflex coronary artery embolism as a complication of subtherapeutic oral anticoagulation in a patient with mitral and aortic mechanical valve prostheses

Postepy w Kardiologii Interwencyjnej

Volumn 9, Issue 1, 2013, Pages 97-100

  Protasiewicz, Marcin ^a   Rojek, Aleksandra ^a   Gajek, Jacek ^a   Mysiak, Andrzej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Anticoagulants; Coronary artery embolism; Valve prostheses

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A INHIBITOR; DOPAMINE; THROMBIN INHIBITOR; VITAMIN K GROUP;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; AORTA VALVE PROSTHESIS; ARTICLE; BLOOD CLOTTING; CASE REPORT; CORONARY ARTERY; CORONARY ARTERY THROMBOSIS; DRUG EFFICACY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HEART VENTRICLE FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MITRAL VALVE PROSTHESIS; PROTHROMBIN TIME; THROMBECTOMY;

EID: 84876267106     PISSN: 17349338     EISSN: 18974295     Source Type: Journal    
DOI: 10.5114/pwki.2013.34034     Document Type: Article

References (9)

1. Rewiuk K, Bednarz S, Faryan P, Grodzicki T. Knowledge of anti thrombotic prophylaxis among patients with atrial fibrillation. Cardiol J 2007; 14: 44-49.
2. Rose AJ, Ozonoff A, Grant RW, et al. Epidemiology of subtherapeutic anticoagulation in the united states. Circ Cardiovasc Qual Outcomes 2009; 2: 591-597.
3. Gurwitz JH, Monette J, Rochon PA, et al. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med 1997; 157: 978-984.
4. Camm AJ. Randomized evaluation of long-term anticoagulant therapy: dabigatran vs. warfarin. Eur Heart J 2009; 30: 2554-2555.
5. Eriksson BI, Dahl OE, Huo MH, et al.; Group R-NIS. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE*). A randomised, double-blind, noninferiority trial. Thromb Haemost 2011; 105: 721-729.
6. Eriksson BI, Dahl OE, Rosencher N, et al.; Group R-NS. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, doubleblind, non-inferiority trial. Lancet 2007; 370: 949-956.
7. Constantinescu MC. Dabigatran is as effective as warfarin in the treatment of acute venous thromboembolism: the re-cover study. Maedica (Buchar) 2010; 5: 77-78.
8. Schulman S. Treatment of venous thromboembolism with dabigatran. Curr Opin Pulm Med 2012.
9. Wann LS, Curtis AB, Ellenbogen KA, et al.; Force ACoCFAHAT. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2011; 123: 1144-1150.